Relationship Between Pulmonary Function Tests and Severity of Coronary Artery Disease in Patients with Chronic Obstructive Pulmonary Disease

Overview

Journal Tanaffos

Specialty Pulmonary Medicine

Date 2020 Dec 2

PMID 33262802

Authors

Arsalan Salari

Fardin Mirbolouk

Asiyeh Ashouri

Pedram Salari

Hanie Shadrou

Zahra Mehdipour

Mahboobeh Gholipour

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to examine relationship between the parameters of pulmonary function and the severity of coronary artery disease (CAD) in chronic obstructive lung disease patients.

Materials And Methods: Four hundred and twenty four patients with ischemic heart diseases who underwent coronary angiography were studied. The demographic characteristics and medical history of the patients were obtained from their medical records.The severity of COPD was determined according to the Global Initiative for Chronic Obstructive Lung Disease. In addition, the severity of CAD was quantified by SYNTAX scoring.

Results: Eighty-eight (21.2%), 270 (65.1%), 52 (12.5%), and 5 (1.2%) of the patients had the grade 1, 2, 3, or 4 COPD, respectively. In addition, 46 (11.1%), 319 (76.9%), and 50 (12.0%) of them had low, intermediate, and high CAD, respectively. A statistically significant relationship was observed between the severity of COPD and the severity of CAD. Significant relationships were found between age, sex, BMI, LDL, EF, and systolic pressure of pulmonary artery with the severity of COPD. The odds of higher CAD in females were 1.849 times higher than male patients. In addition, the odds of high CAD in the patients with grade 1 or 2 COPD were 0.006 and 0.068 times of the patients with grades 3 and 4 COPD, respectively.

Conclusions: The findings of the present study indicate that the parameters of pulmonary function and the severity of CAD are associated with the severity of COPD.

References

Houben J, Mercken E, Ketelslegers H, Bast A, Wouters E, Hageman G . Telomere shortening in chronic obstructive pulmonary disease. Respir Med. 2008; 103(2):230-6. DOI: 10.1016/j.rmed.2008.09.003. View

Medina A, Martin P, Suarez de Lezo J, Amador C, de Lezo J, Pan M . Vulnerable carina anatomy and ostial lesions in the left anterior descending coronary artery after floating-stent treatment. Rev Esp Cardiol. 2009; 62(11):1240-9. DOI: 10.1016/s1885-5857(09)73351-1. View

Hochner-Celnikier D, Manor O, Gotzman O, Lotan H, Chajek-Shaul T . Gender gap in coronary artery disease: comparison of the extent, severity and risk factors in men and women aged 45-65 years. Cardiology. 2002; 97(1):18-23. DOI: 10.1159/000047414. View

Nagelmann A, Tonnov A, Laks T, Sepper R, Prikk K . Lung dysfunction of chronic smokers with no signs of COPD. COPD. 2011; 8(3):189-95. DOI: 10.3109/15412555.2011.565090. View

Hodge S, Hodge G, Jersmann H, Matthews G, Ahern J, Holmes M . Azithromycin improves macrophage phagocytic function and expression of mannose receptor in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008; 178(2):139-48. DOI: 10.1164/rccm.200711-1666OC. View

Curkendall S, DeLuise C, Jones J, Lanes S, Stang M, Goehring Jr E . Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol. 2005; 16(1):63-70. DOI: 10.1016/j.annepidem.2005.04.008. View

Dursunoglu N, Dursunoglu D, Yildiz A, Uludag B, Alacam Z, Saricopur A . Severity of coronary atherosclerosis in patients with COPD. Clin Respir J. 2015; 11(6):751-756. DOI: 10.1111/crj.12412. View

Feghali-Bostwick C, Gadgil A, Otterbein L, Pilewski J, Stoner M, Csizmadia E . Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007; 177(2):156-63. PMC: 2204079. DOI: 10.1164/rccm.200701-014OC. View

Kosuge M, Kimura K, Ishikawa T, Shimizu T, Sugano T, Sumita S . Different clinical and coronary angiographic findings according to ratios of total cholesterol to high-density lipoprotein cholesterol during the acute phase of myocardial infarction. J Cardiol. 2004; 43(6):251-8. View

10.

Bridges C, Califf R, Casey Jr D, Chavey 2nd W, Fesmire F, Hochman J . ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to.... J Am Coll Cardiol. 2007; 50(7):e1-e157. DOI: 10.1016/j.jacc.2007.02.013. View

11.

Hole D, Watt G, Davey-Smith G, Hart C, Gillis C, Hawthorne V . Impaired lung function and mortality risk in men and women: findings from the Renfrew and Paisley prospective population study. BMJ. 1996; 313(7059):711-5; discussion 715-6. PMC: 2352103. DOI: 10.1136/bmj.313.7059.711. View

12.

Ram F, Jardin J, Atallah A, Castro A, Mazzini R, Goldstein R . Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Med. 2005; 99(2):135-44. DOI: 10.1016/j.rmed.2004.10.009. View

13.

Zhu Z, Wang X, Li X, Lin Y, Shen S, Liu C . Genetic overlap of chronic obstructive pulmonary disease and cardiovascular disease-related traits: a large-scale genome-wide cross-trait analysis. Respir Res. 2019; 20(1):64. PMC: 6444755. DOI: 10.1186/s12931-019-1036-8. View

14.

Blomstrom-Lundqvist C, Scheinman M, Aliot E, Calkins H, Camm A, Campbell W . ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of.... J Am Coll Cardiol. 2003; 42(8):1493-531. DOI: 10.1016/j.jacc.2003.08.013. View

15.

Kreatsoulas C, Natarajan M, Khatun R, Velianou J, Anand S . Identifying women with severe angiographic coronary disease. J Intern Med. 2010; 268(1):66-74. DOI: 10.1111/j.1365-2796.2009.02210.x. View

16.

Tukek T, Yildiz P, Akkaya V, Karan M, Atilgan D, Yilmaz V . Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann Noninvasive Electrocardiol. 2002; 7(3):222-7. PMC: 7027775. DOI: 10.1111/j.1542-474x.2002.tb00167.x. View

17.

Lamprecht B, McBurnie M, Vollmer W, Gudmundsson G, Welte T, Nizankowska-Mogilnicka E . COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2010; 139(4):752-763. PMC: 3168866. DOI: 10.1378/chest.10-1253. View

18.

Sidney S, Sorel M, Quesenberry Jr C, DeLuise C, Lanes S, Eisner M . COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest. 2005; 128(4):2068-75. DOI: 10.1378/chest.128.4.2068. View

19.

Topsakal R, Kalay N, Ozdogru I, Cetinkaya Y, Oymak S, Gungor Kaya M . Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels. 2009; 24(3):164-8. DOI: 10.1007/s00380-008-1103-4. View

20.

Syvanne M, Pajunen P, Kahri J, Lahdenpera S, Ehnholm C, Nieminen M . Determinants of the severity and extent of coronary artery disease in patients with type-2 diabetes and in nondiabetic subjects. Coron Artery Dis. 2001; 12(2):99-106. DOI: 10.1097/00019501-200103000-00003. View